Executive Summary

The mechanism of patent opposition pre-grant post-grant under the Patents Act 1970 represents India’s statutory commitment to ensuring that patents are granted only for genuinely novel, non-obvious, and patentable subject matter. The opposition framework — comprising pre-grant opposition under Section 25(1) and post-grant opposition under Section 25(2) of the Patents Act 1970 — provides structured avenues through which third parties may challenge patent applications before grant and granted patents within a defined window after grant. These mechanisms are of particular strategic significance in sectors such as pharmaceuticals, biotechnology, electronics, and information technology, where the grant of an overbroad or invalid patent may have substantial commercial and public interest consequences.

India’s opposition framework has attracted international attention, particularly in the pharmaceutical sector, where Section 3(d) of the Patents Act 1970 — which limits patentability of new forms of known substances to those demonstrating enhanced efficacy — combined with the pre-grant opposition mechanism, has served as a significant gatekeeping instrument. This article provides a comprehensive analysis of the statutory provisions, procedural stages, strategic considerations, and judicial landscape governing patent opposition proceedings in India as of June 2026.

Statutory Framework

Patents Act 1970: The Foundation

The Patents Act 1970, as amended significantly by the Patents (Amendment) Act 2005 (which brought India into compliance with the TRIPS Agreement), is the principal legislation governing patent oppositions. The 2005 amendment restructured the opposition framework, expanding the grounds for pre-grant opposition and significantly strengthening the post-grant opposition provisions.

Pre-Grant Opposition: Section 25(1)

Section 25(1) of the Patents Act 1970 provides that where an application for a patent has been published but a patent has not yet been granted, any person may represent to the Controller of Patents by way of opposition to the grant of the patent. The standing is broad — “any person” is entitled to file a pre-grant opposition, without the need to demonstrate any particular interest or status. This is a deliberate policy choice that distinguishes pre-grant opposition from post-grant opposition, where standing is limited to “any person interested.”

The grounds available under Section 25(1) include: (a) wrongful obtaining of the invention; (b) prior publication of the invention before the priority date of the claim; (c) prior claiming of the invention in another patent application in India having an earlier priority date; (d) prior public knowledge or prior public use in India of the invention before the priority date; (e) obviousness and lack of inventive step; (f) non-patentable subject matter under Section 3 or Section 4; (g) insufficiency of description — the complete specification does not sufficiently and fairly describe the invention or the method by which it is to be performed; (h) non-disclosure or wrong mention of the source or geographical origin of biological material; (i) anticipation of the invention by traditional knowledge of any community, anywhere in the world.

Section 3 of the Patents Act 1970 sets out an extensive list of subject matter that is not an invention for the purposes of the Act, including: inventions contrary to public order or morality; mere discoveries of scientific principles; mathematical or business methods, computer programmes per se, or algorithms; rules for playing games; methods of treatment of human or animal bodies; plants and animals; topography of integrated circuits; and, critically in Section 3(d), new forms of known substances unless they differ significantly in properties with regard to efficacy.

Post-Grant Opposition: Section 25(2)

Section 25(2) of the Patents Act 1970 provides that at any time after the grant of a patent but before the expiry of one year from the date of publication of the grant, any person interested may give notice of opposition to the Controller of Patents. The twelve-month window from the date of publication of the grant is a hard deadline, and there is no provision for condonation of delay in filing a post-grant opposition.

The grounds for post-grant opposition under Section 25(2) are substantially similar to those available under Section 25(1), encompassing: wrongful obtaining; prior publication; prior claiming; prior public knowledge or use; obviousness; non-patentable subject matter under Sections 3 and 4; insufficiency; failure to disclose information under Section 8 (which requires an applicant to disclose information regarding corresponding foreign patent applications); and non-disclosure of source or geographical origin of biological material. The standing requirement — “any person interested” — is narrower than the “any person” standard for pre-grant opposition, though the courts have interpreted “person interested” broadly to include persons engaged in trade or industry related to the patented subject matter.

Revocation under Section 64

In addition to post-grant opposition under Section 25(2), Section 64 of the Patents Act 1970 provides for revocation of a patent by a petition to the High Court. After the Tribunals Reforms Act 2021 abolished the Intellectual Property Appellate Board (IPAB), the jurisdiction of the IPAB under the Patents Act was transferred to the respective High Courts. Section 64 revocation proceedings before the High Court are available on overlapping but broader grounds than post-grant opposition, and they may be filed at any time during the life of the patent — not just within the twelve-month window available for post-grant opposition. A revocation petition under Section 64 may also be filed as a counterclaim in a patent infringement suit.

The Tribunals Reforms Act 2021 and the Abolition of IPAB

The Tribunals Reforms (Rationalisation and Conditions of Service) Act 2021 abolished the Intellectual Property Appellate Board (IPAB) with effect from 4 April 2021. Prior to abolition, appeals from post-grant opposition orders of the Controller lay to the IPAB. Following abolition, appeals from the Controller’s orders in post-grant opposition proceedings lie to the High Court of competent jurisdiction. This change has had significant procedural implications: the High Courts (particularly the Delhi High Court, which has established a dedicated Intellectual Property Division) are now the appellate forum for all patent matters, including post-grant opposition orders.

Procedural Landscape

Pre-Grant Opposition Procedure

Stage 1: Filing the Representation. Any person may file a pre-grant opposition (formally called a “representation”) to the Controller of Patents at the relevant Patent Office (Delhi, Mumbai, Chennai, or Kolkata, depending on the applicant’s jurisdiction) after publication of the application in the Official Journal of the Patent Office and before the grant of the patent. The representation must be in Form 7A (prescribed under the Patents Rules 2003) and must set out the grounds of opposition supported by a statement and evidence. The representation must identify at least one of the statutory grounds under Section 25(1).

Stage 2: Examination of Representation by the Controller. The Controller notifies the applicant of the representation and gives the applicant an opportunity to respond. The examination of a pre-grant opposition is informal compared to post-grant opposition — there are no prescribed evidence rounds or Opposition Board proceedings. The Controller (through the examiner) considers the representation along with the applicant’s response and determines whether the representation has merit sufficient to influence the grant decision. If the Controller finds the representation prima facie worthy of consideration, the objections raised may be incorporated into the examination of the complete specification.

Stage 3: Hearing. The Controller may, at the Controller’s discretion, fix a hearing at which the opponent and the applicant may be heard before a decision is made on whether to grant the patent. A hearing is not mandatory in pre-grant opposition, and in practice, many pre-grant representations are decided on the papers.

Stage 4: Grant or Refusal. The Controller either grants the patent (with or without amendment to the claims) or refuses grant. There is no separate order disposing of the pre-grant opposition as such — the grant or refusal of the patent is itself the outcome of the process.

Appeal. A pre-grant opponent has limited appellate rights. The applicant may appeal against refusal of the patent to the High Court. The pre-grant opponent, not being an applicant, has no direct right of appeal against a grant — but may subsequently file a post-grant opposition within twelve months of publication of the grant, or may petition for revocation under Section 64 before the High Court.

Post-Grant Opposition Procedure

Stage 1: Notice of Opposition. The opponent (any person interested) files a Notice of Opposition in Form 7 prescribed under the Patents Rules 2003, along with a statement setting out the grounds of opposition, supported by evidence in the form of affidavits and exhibits. The notice must be filed at the Patent Office where the patent was granted.

Stage 2: Patentee’s Reply. The Controller serves the Notice of Opposition and supporting documents on the patentee. The patentee has one month (extendable by the Controller) to file a reply statement along with evidence in support of the patent.

Stage 3: Opponent’s Evidence in Reply. The opponent may file evidence strictly in reply to the patentee’s evidence within one month (extendable) of receipt of the patentee’s evidence.

Stage 4: Constitution of Opposition Board. After the completion of evidence rounds, the Controller constitutes an Opposition Board comprising three officers. The Opposition Board examines the materials on record and submits a report with its recommendations to the Controller on each of the grounds of opposition.

Stage 5: Oral Hearing. The Controller fixes a date for an oral hearing at which both the opponent and the patentee may be heard. The parties may appear in person or through registered patent agents or advocates.

Stage 6: Controller’s Decision. After considering the Opposition Board’s report and hearing the parties, the Controller passes an order either maintaining the patent as granted, amending the patent, or revoking the patent. The Controller’s order must be a reasoned order addressing each ground of opposition.

Stage 7: Appeal to High Court. Either party may appeal against the Controller’s order in post-grant opposition to the High Court of competent jurisdiction under Section 117A of the Patents Act. Following the abolition of IPAB, the High Court is the appellate forum.

Strategic Comparison: Pre-Grant vs Post-Grant Opposition

Key Judicial Precedents

Novartis AG v. Union of India (2013) 6 SCC 1

The Supreme Court of India’s decision in Novartis AG v. Union of India remains the most consequential judicial pronouncement on the Indian patent opposition framework. The case arose from Novartis’s patent application for the beta crystalline form of imatinib mesylate (Gleevec / Glivec), a cancer treatment drug. The application was rejected by the Controller following a pre-grant opposition under Section 25(1), and Novartis’s challenge ultimately reached the Supreme Court.

The Supreme Court held that Section 3(d) of the Patents Act 1970 is constitutionally valid and does not violate India’s TRIPS obligations. The court interpreted the “efficacy” standard in Section 3(d) as referring to therapeutic efficacy in the case of pharmaceutical substances — a higher bar than mere physico-chemical property improvement. On the facts, the court upheld the rejection of the patent application, finding that the beta crystalline form of imatinib mesylate did not demonstrate the requisite enhancement in therapeutic efficacy over the known compound. The decision affirmed the broad grounds available in pre-grant opposition and the Controller’s power to refuse a patent on Section 3(d) grounds even in the case of commercially significant pharmaceutical compounds.

F. Hoffmann-La Roche Ltd v. Cipla Ltd (Delhi High Court)

In the series of proceedings involving Roche’s erlotinib (Tarceva) patent — including the Delhi High Court’s examination of the patent’s validity in the context of infringement proceedings — the High Court examined the intersection of Section 64 revocation and the post-grant opposition framework. The proceedings established the principle that revocation under Section 64 before the High Court is a separate and independent remedy from post-grant opposition under Section 25(2), and that invalidity arguments may be raised in the High Court regardless of whether a post-grant opposition has been filed.

Enercon (India) Ltd v. Aloys Wobben (2013) 5 SCC 1

In Enercon, the Supreme Court examined the jurisdiction of the IPAB (now vested in the High Court following the Tribunals Reforms Act 2021) in patent proceedings and affirmed that the appellate forum’s jurisdiction over Controller orders is broad, encompassing questions of fact and law. The decision is relevant to the understanding of the scope of the High Court’s appellate jurisdiction following the IPAB’s abolition.

Conclusion

The patent opposition pre-grant post-grant framework under the Patents Act 1970 provides a robust two-stage mechanism for challenging the validity of patents in India. Pre-grant opposition under Section 25(1) is accessible to any person, is relatively informal and cost-effective, and is best deployed where the opponent’s primary objective is to prevent the grant of a patent — particularly in pharmaceutical and technology sectors where Section 3(d), Section 3(k) (computer programs per se), or obviousness grounds are available on the face of the published specification.

Post-grant opposition under Section 25(2) provides a more structured and procedurally rigorous forum, with full evidence rounds, an Opposition Board, and an oral hearing. It is the appropriate mechanism where the opponent has gathered substantial evidence — prior art documents, expert declarations, or disclosure failures — that requires a considered evidential process to present effectively. The twelve-month hard deadline from publication of grant must be rigorously observed.

Revocation under Section 64 before the High Court remains available as a separate route at any time during the patent’s life, particularly following the IPAB’s abolition, which has elevated the High Courts as the primary patent adjudicatory forum. The Delhi High Court’s Intellectual Property Division has developed a sophisticated body of jurisprudence on patent validity that provides guidance on the standards applicable across all categories of patent challenge. Practitioners navigating patent opposition strategy in India in 2026 must integrate these procedural options with a clear view of the strength of available prior art, the commercial stakes involved, and the time and cost constraints of the opposition mechanism selected.

The post Patent Opposition in India: Pre-Grant vs Post-Grant — Procedure and Strategy appeared first on Bhatt & Joshi Associates.